A Phase 1/2a Placebo-controlled, Randomized, Double-blind, Sponsor-unblinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of Staphylococcus Aureus 4-antigen Vaccine (sa4ag) In Japanese Adults
Phase of Trial: Phase I/II
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Staphylococcus aureus vaccine (Primary)
- Indications Staphylococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Pfizer
- 05 Oct 2016 Status changed from active, no longer recruiting to completed.
- 13 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 15 Jul 2015 New trial record